iShares Biotechnology ETF
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Total operating expenses were $6,926,610.
Profit Margin
| 2010 | 5.81M | 444.26M | 7645.29% |
|---|
IBB Income Statement (2010 – 2010)
| 2010 | |
|---|---|
Revenue | |
Revenue | 5.81M |
Cost of revenue | 0 |
Gross profit | 0 |
Operating exp. | |
Research and development | 0 |
Selling and marketing | 0 |
Total operating expenses | 6.92M |
Operating income | -1.11M |
Other income (expenses), net | -445.37M |
Income before tax | 444.26M |
Income tax expense | 0 |
Net income | 444.26M |
Earnings per share | |
Basic EPS | 8.34 |
Diluted EPS | 8.34 |